Published: Apr, 2018
The increasing issues of high dependence on nicotine and subsequent health problems have led to the creation of many opportunities in the global market for products of smoking cessation and nicotine de-addiction. Some of the key players in the global smoking cessation and nicotine de-addiction products market include names such as Novartis, GlaxoSmithKline, Pfizer, GSK, Johnson & Johnson, VMR Products LLC, Lorillard Inc., NJOY, and Nicotek LLC. These players are making considerable investments in carrying out clinical experiments to examine efficacy and safety to the products. Moreover, the companies are also bolstering their channels of distribution to expand their geographical reach of their products. Companies are taking strategic decisions such as mergers and acquisitions to enhance their market share. Recently NJOY LLC procured the assets of NJOY INC. as the former company completed its financial restructuring. This has marked a fresh financial start for the brand NJOY and is expected to function better in the market with added liquidity due to this acquisition.
The global market for smoking cessation and nicotine de-addiction products stood is expected to reach an overall valuation of US$20.55 bn by the end of 2023. The market is projected to achieve this growth at a CAGR of 14% over the course of the forecast period of 2017-2023. It is expected that during this forecast period, the sale of e-cigarette will rise as the customers will prefer this type of therapy to quit their smoking addiction or cut down the nicotine dependency. Geographically, it is projected that North America market will contribute majorly to the global market and reach the overall valuation of US$8.59 bn by 2023.
Ill Effects of Smoking Propel Demand for Smoking Cessation and Nicotine De-Addiction Products
The increasing awareness among cigarette smokers about the health disadvantages of smoking and nicotine such as cardiac diseases, lung cancer, and other different respiratory problems has propelled the global cigarette cessation and nicotine de-addiction products market. The initiatives backed by governments to create awareness about the ill effects of smoking with the help of information brochures, television advertisements, warning labels and discouraging imagery on cigarette packages, and newspapers are also helping to drive the market. Moreover, availability of a wide range of NRT products through online selling platforms and retail is also fueling the overall growth of the market.
This rising awareness is also backed by de-addiction camps and help centers that make use of the smoking cessation and nicotine de-addiction products to aid smokers for long term. Retailing of such products has turned out to be an efficient strategy towards educating the masses and also generating high revenues and profits. The launch of new products is driving the global market as well as motivating smoking addicts to quit. The introduction of e-cigarettes has completely revolutionized the viewpoint towards de-addiction among numerous smokers.
Lack of Awareness in Emerging Economies Impede Market Growth
In contrast, poor awareness about the smoking cessation and nicotine de-addiction products in the emerging economies such as China, Russia, and India are playing a significant role in impeding the market growth. Many smoking cessation and nicotine de-addiction products were launched very late in these markets and thus the growth in these market is at a very nascent stage. Moreover, the distribution and penetration of other smoking cessation and nicotine de-addiction products such as patches, inhalers, and lozenges is also significantly low. This has also led to slowing down the growth of the global market.
This review is based on the research report published by Transparency Market Research titled “Smoking Cessation and Nicotine De-Addiction Products Market (Nicotine Replacement Therapy Products (Nicotine Gums, Nicotine Transdermal Patches, Nicotine Lozenges, Nicotine Sprays, Nicotine Inhalers, and Nicotine Sublingual Tablets), Drug Therapy (Zyban (bupropion) and Chantix/Champix (varenicline)), and E-cigarettes) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2023.”
- Government initiatives to create awareness against ill-effects of smoking fuels growth
- De-addiction camps and help centers to aid smokers boosts uptake of smoking cessation products
The global smoking cessation and nicotine de-addiction products market is segmented as follows;
Smoking Cessation and Nicotine De-Addiction Products Market, by Type
- Nicotine Replacement Therapy Products
- Nicotine Gums
- Nicotine Transdermal Patches
- Nicotine Lozenges
- Nicotine Sprays
- Nicotine Inhalers
- Nicotine Sublingual Tablets
- Drug Therapy
- Zyban (bupropion)
- Chantix/Champix (varenicline)
Smoking Cessation and Nicotine De-Addiction Products Market, by Geography
- North America
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Rest of the World (RoW)
- Latin America (LATAM)
- Middle East and North Africa (MENA)
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”
Transparency Market Research
90 State Street,
Albany NY - 12207